Plus Therapeutics | CYTX - Ebit

Stock Price
0.30
Daily Change
-0.01 -2.88%
Monthly
15.47%
Yearly
-79.16%
Q1 Forecast
0.29

Plus Therapeutics reported $-4.72M in EBIT for its fiscal quarter ending in March of 2023.





Ebit Change Date
Baxter International USD -214.2M 415.4M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Northwest Biotherapeutics USD -13.82M 248K Sep/2023
Sanofi EUR 1.7B 2.17B Dec/2025
Starpharma Holdings AUD -873K 161K Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025